Arthur Kuan - 15 Apr 2025 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Role
Chief Executive Officer, Director
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Arthur Kuan
Issuer symbol
CGON
Transactions as of
15 Apr 2025
Net transactions value
$0
Form type
4
Filing time
16 Apr 2025, 16:15:18 UTC
Previous filing
07 Oct 2024
Next filing
06 Mar 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGON Employee Stock Option (Right to Buy) Award $0 +527,660 $0.000000 527,660 15 Apr 2025 Common Stock 527,660 $20.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly following April 15, 2025, the vesting commencement date, subject to the Report Person's continuous service to the Issuer through each vesting date.